Lupin is currently trading at Rs. 931.25, up by 11.90 points or 1.29% from its previous closing of Rs. 919.35 on the BSE.
The scrip opened at Rs. 920.00 and has touched a high and low of Rs. 936.25 and Rs. 908.00 respectively. So far 112425 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1090.00 on 30-Oct-2017 and a 52 week low of Rs. 723.55 on 15-May-2018.
Last one week high and low of the scrip stood at Rs. 958.00 and Rs. 896.80 respectively. The current market cap of the company is Rs. 41864.26 crore.
The promoters holding in the company stood at 47.01%, while Institutions and Non-Institutions held 37.89% and 15.10% respectively.
Lupin is expecting to train more than 1,000 under graduates into pharma professionals by the year 2020 under its Learn and Earn Initiative. The company has launched its 'Learn and Earn' initiative in which candidate who has passed Standard 12 in the science stream with a minimum of 50 per cent marks but are facing financial constraints are taken for three-year-long course during which they are paid stipend and provided all the facilities.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
